Call us: +44 870 8 200 310
Or write: experts@regartis.com
full study report
| Page | Keyword count |
| TITLE I: GENERAL ISSUES | |
| CHAPTER 2: Definitions and general provision | |
| Article 3: Definitions | 4 |
| TITLE II: REGISTRATION OF SUBSTANCES | |
| CHAPTER 1: General obligation to register and information requirements | |
| Article 10: Information to be submitted for general registration purposes | 1 |
| CHAPTER 3: Obligation to register and information requirements for certain types of isolated intermediates | |
| Article 17: Registration of on-site isolated intermediates | 2 |
| Article 18: Registration of transported isolated intermediates | 2 |
| TITLE III: DATA SHARING AND AVOIDANCE OF UNNECESSARY TESTING | |
| CHAPTER 2: Rules for non-phase-in substances and registrants of phase-in substances who have not pre-registered | |
| Article 27: Sharing of existing data in the case of registered substances | 2 |
| CHAPTER 3: Rules for phase-in-substances | |
| Article 30: Sharing of data involving tests | 3 |
| TITLE VI: EVALUATION | |
| CHAPTER 4: Common provisions | |
| Article 53: Cost sharing for tests without an agreement between registrants and/or downstream users | 2 |